Cargando…
Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149233/ https://www.ncbi.nlm.nih.gov/pubmed/35007383 http://dx.doi.org/10.1111/ajt.16954 |
| _version_ | 1785035124294811648 |
|---|---|
| author | Bertrand, Dominique Lemée, Veronique Laurent, Charlotte Lemoine, Mathilde Hanoy, Mélanie Le Roy, Frank Nezam, Dorian Pruteanu, Diana Lebourg, Ludivine Grange, Steven Plantier, Jean-Christophe Boyer, Olivier Guerrot, Dominique Candon, Sophie |
| author_facet | Bertrand, Dominique Lemée, Veronique Laurent, Charlotte Lemoine, Mathilde Hanoy, Mélanie Le Roy, Frank Nezam, Dorian Pruteanu, Diana Lebourg, Ludivine Grange, Steven Plantier, Jean-Christophe Boyer, Olivier Guerrot, Dominique Candon, Sophie |
| author_sort | Bertrand, Dominique |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10149233 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101492332023-05-01 Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients Bertrand, Dominique Lemée, Veronique Laurent, Charlotte Lemoine, Mathilde Hanoy, Mélanie Le Roy, Frank Nezam, Dorian Pruteanu, Diana Lebourg, Ludivine Grange, Steven Plantier, Jean-Christophe Boyer, Olivier Guerrot, Dominique Candon, Sophie Am J Transplant Letter to the Editor American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022-05 2022-12-30 /pmc/articles/PMC10149233/ /pubmed/35007383 http://dx.doi.org/10.1111/ajt.16954 Text en Copyright © 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Bertrand, Dominique Lemée, Veronique Laurent, Charlotte Lemoine, Mathilde Hanoy, Mélanie Le Roy, Frank Nezam, Dorian Pruteanu, Diana Lebourg, Ludivine Grange, Steven Plantier, Jean-Christophe Boyer, Olivier Guerrot, Dominique Candon, Sophie Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title | Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title_full | Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title_fullStr | Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title_full_unstemmed | Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title_short | Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients |
| title_sort | waning antibody response and cellular immunity 6 months after third dose sars-cov-2 mrna bnt162b2 vaccine in kidney transplant recipients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149233/ https://www.ncbi.nlm.nih.gov/pubmed/35007383 http://dx.doi.org/10.1111/ajt.16954 |
| work_keys_str_mv | AT bertranddominique waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT lemeeveronique waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT laurentcharlotte waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT lemoinemathilde waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT hanoymelanie waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT leroyfrank waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT nezamdorian waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT pruteanudiana waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT lebourgludivine waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT grangesteven waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT plantierjeanchristophe waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT boyerolivier waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT guerrotdominique waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients AT candonsophie waningantibodyresponseandcellularimmunity6monthsafterthirddosesarscov2mrnabnt162b2vaccineinkidneytransplantrecipients |